A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma

BACKGROUND: Many in vitro studies have demonstrated that silencing of cancerous genes by siRNAs is a potential therapeutic approach for blocking tumor growth. However, siRNAs are not cell type-selective, cannot specifically target tumor cells, and therefore have limited in vivo application for siRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Nianxi, Bagaria, Hitesh G, Wong, Michael S, Zu, Youli
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045295/
https://www.ncbi.nlm.nih.gov/pubmed/21281497
http://dx.doi.org/10.1186/1477-3155-9-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045295/
https://www.ncbi.nlm.nih.gov/pubmed/21281497
http://dx.doi.org/10.1186/1477-3155-9-2

Ejemplares similares